Biomatics Capital Partners
Overview
Biomatics Capital is a venture capital firm focused on transforming the future of healthcare through strategic investments in genomics and digital data. The firm aims to develop superior therapeutics, diagnostics, and delivery models that lead to a value-based healthcare system with lower costs and better patient outcomes. The firm seeks to invest in companies operating in the healthcare, technology and life science sectors. Biomatics Capital partners with entrepreneurs to support groundbreaking technologies and create exceptional value through a network of experts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GRAIL | Jan 2016 | Series A | - |
| Aledade | Jan 2017 | Series B Extension | Lead |
| Verve | Jan 2021 | Series B | - |
| Variant Bio | May 2020 | Series A | Co-investor |
| AiCure | Nov 2019 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Julie Sunderland
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Biomatics Capital Partners based?
Biomatics Capital Partners is headquartered in Seattle, Washington, United States.
When was Biomatics Capital Partners founded?
Biomatics Capital Partners was founded in 2016.
How many portfolio companies does Biomatics Capital Partners have?
Biomatics Capital Partners has 13 portfolio companies in Caplight's dataset.
What are some companies in Biomatics Capital Partners's portfolio?
Portfolio companies visible on Caplight include GRAIL, Aledade, Verve, Variant Bio, AiCure.
What was Biomatics Capital Partners's most recent investment shown here?
Biomatics Capital Partners's most recent investment in this portfolio sample was in Verve in 2021.
What sectors does Biomatics Capital Partners focus on?
Biomatics Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Biomatics Capital Partners focus on?
Biomatics Capital Partners typically invests at the Mid stage.
What is Biomatics Capital Partners's AUM?
Biomatics Capital Partners's assets under management are estimated between $250.0M and $500.0M.